Targeted Acne Spot Treatment
Product Images NDC 59779-266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Targeted Acne Spot Treatment (NDC 59779-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Back)

Image Description (Back)
This is a Drug Facts label for a product that contains Benzopperoid 2%, which is used to treat and prevent acne blemishes. There are warnings stating that it is for external use only and should not be used by people with sensitive skin or a sensitivity to benzoyl peroxide. The product should be kept out of reach of children and may bleach hair or dyed fabrics. The directions explain how to apply the product, including starting with one application per day and gradually increasing the frequency. If any irritation or sensitivity develops, use of both products should stop and a doctor should be consulted. The other ingredients in the product are listed as well.*
FDA Label Image

Image Description (Front)

Image Description (Front)
This is a targeted acne spot treatment with maximum strength effectiveness that comes in a 0.75 oz (21 g) product size. It claims to cause less irritation and not dry out skin. The product is distributed by CVS Pharmacy, Inc. and is not manufactured or distributed by Johnson & Johnson, the distributor of Neutrogena Onehe-Spot Acne Treatment. Contact information for CVS Pharmacy is provided at the bottom.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.